VOYA Investment Management
PTGX icon

VOYA Investment Management’s Protagonist Therapeutics PTGX Stock Holding History

VOYA Investment Management’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.1M Buy
571,618
+117,235
+26% +$12.2M 0.06% 255
2026
Q1 		$47.9M Buy
454,383
+88,218
+24% +$7.81M 0.05% 292
2025
Q4 		$32M Buy
366,165
+60,746
+20% +$4.97M 0.03% 403
2025
Q3 		$20.3M Buy
305,419
+25,065
+9% +$1.42M 0.02% 493
2025
Q2 		$15.5M Buy
280,354
+220,676
+370% +$10.6M 0.02% 604
2025
Q1 		$2.89M Sell
59,678
-22,949
-28% -$962K ﹤0.01% 1153
2024
Q4 		$3.19M Sell
82,627
-31,225
-27% -$1.36M ﹤0.01% 1119
2024
Q3 		$5.12M Buy
113,852
+48,786
+75% +$1.97M 0.01% 986
2024
Q2 		$2.25M Sell
65,066
-4,377
-6% -$128K ﹤0.01% 1278
2024
Q1 		$2.01M Buy
69,443
+26,198
+61% +$713K ﹤0.01% 1347
2023
Q4 		$992K Buy
43,245
+282
+0.7% +$4.93K ﹤0.01% 1683
2023
Q3 		$717K Buy
42,963
+1,374
+3% +$26.7K ﹤0.01% 1847
2023
Q2 		$1.15M Sell
41,589
-52,468
-56% -$1.31M ﹤0.01% 1589
2023
Q1 		$2.16M Sell
94,057
-45,342
-33% -$761K ﹤0.01% 1328
2022
Q4 		$1.52M Sell
139,399
-7,060
-5% -$59.6K ﹤0.01% 1446
2022
Q3 		$1.23M Buy
146,459
+129,091
+743% +$1.22M ﹤0.01% 1523
2022
Q2 		$137K Hold
17,368
– – ﹤0.01% 2542
2022
Q1 		$411K Hold
17,368
– – ﹤0.01% 2015
2021
Q4 		$594K Sell
17,368
-69
-0.4% -$2.18K ﹤0.01% 1900
2021
Q3 		$309K Buy
17,437
+1,187
+7% +$50.6K ﹤0.01% 2334
2021
Q2 		$729K Buy
16,250
+1,156
+8% +$38.2K ﹤0.01% 1860
2021
Q1 		$391K Buy
15,094
+2,023
+15% +$51.2K ﹤0.01% 2164
2020
Q4 		$264K Buy
13,071
+3,045
+30% +$65.5K ﹤0.01% 2264
2020
Q3 		$196K Buy
+10,026
New +$188K ﹤0.01% 2163

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

VOYA Investment Management's PTGX Position: Q2 2026 in Review

VOYA Investment Management increased its Protagonist Therapeutics (PTGX) stake by 26% in Q2 2026, buying an estimated $12.2M and bringing the position to 571,618 shares worth $70.1M. The position accounts for 0.06% of the portfolio, ranked #255.

VOYA Investment Management first reported a position in PTGX in Q3 2020 and has held it in 24 quarters since. 343 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • VOYA Investment Management held 571,618 shares of Protagonist Therapeutics worth $70.1M as of Q2 2026.
  • VOYA Investment Management bought 117,235 Protagonist Therapeutics shares in Q2 2026, an estimated $12.2M.
  • Protagonist Therapeutics made up 0.06% of VOYA Investment Management's portfolio in Q2 2026, its #255 holding.
  • VOYA Investment Management first reported a position in Protagonist Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 343 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.